Armata Pharmaceuticals Q1 EPS $(0.20) Beats $(0.38) Estimate, Sales $491.00K Miss $1.38M Estimate

Author: Benzinga Newsdesk | May 14, 2025 04:23pm
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.38) by 47.37 percent. This is a 71.01 percent increase over losses of $(0.69) per share from the same period last year. The company reported quarterly sales of $491.00 thousand which missed the analyst consensus estimate of $1.38 million by 64.42 percent. This is a 49.17 percent decrease over sales of $966.00 thousand the same period last year.

Posted In: ARMP